BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38158377)

  • 1. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus.
    Tsuyama S; Kohsaka S; Hayashi T; Suehara Y; Hashimoto T; Kajiyama Y; Tsurumaru M; Ueno T; Mano H; Yao T; Saito T
    Histopathology; 2021 Jan; 78(2):240-251. PubMed ID: 32654197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
    Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P
    G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.
    Lasota J; Kowalik A; Felisiak-Golabek A; Zięba S; Waloszczyk P; Masiuk M; Wejman J; Szumilo J; Miettinen M
    Mod Pathol; 2019 Jul; 32(7):957-966. PubMed ID: 30760858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
    Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
    Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
    Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
    Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
    Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences.
    Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP
    Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognosis of primary malignant melanoma of the esophagus.
    Chen H; Fu Q; Sun K
    Medicine (Baltimore); 2020 Jul; 99(28):e20957. PubMed ID: 32664098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach.
    Kim KB; Soroceanu L; de Semir D; Millis SZ; Ross J; Vosoughi E; Dar AA; Nosrati M; Desprez PY; Ice R; Chen M; Chetal K; Bhattacharjee A; Moretto J; Leong SP; Singer MI; Parrett BM; Minor DR; McAllister S; Miller JR; Salomonis N; Kashani-Sabet M
    J Invest Dermatol; 2021 Aug; 141(8):2028-2036.e2. PubMed ID: 33610559
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
    Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations.
    Williams EA; Montesion M; Shah N; Sharaf R; Pavlick DC; Sokol ES; Alexander B; Venstrom J; Elvin JA; Ross JS; Williams KJ; Tse JY; Mochel MC
    Mod Pathol; 2020 Dec; 33(12):2397-2406. PubMed ID: 32483240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus.
    Li J; Guan W; Ren W; Liu Z; Wu H; Chen Y; Liu S; Quan X; Yang Z; Jiang C; He J; Xiao X; Ye Q
    Neoplasia; 2022 Aug; 30():100811. PubMed ID: 35661532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Harada K; Mine S; Yamada K; Shigaki H; Oya S; Baba H; Watanabe M
    Dis Esophagus; 2016 May; 29(4):314-9. PubMed ID: 25708974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and patient outcome of melanoma nodal metastases and an unknown primary site.
    Gos A; Jurkowska M; van Akkooi A; Robert C; Kosela-Paterczyk H; Koljenović S; Kamsukom N; Michej W; Jeziorski A; Pluta P; Verhoef C; Siedlecki JA; Eggermont AM; Rutkowski P
    Ann Surg Oncol; 2014 Dec; 21(13):4317-23. PubMed ID: 24866436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review.
    Zhou SL; Zhang LQ; Zhao XK; Wu Y; Liu QY; Li B; Wang JJ; Zhao RJ; Wang XJ; Chen Y; Wang LD; Kong LF
    World J Gastrointest Oncol; 2022 Sep; 14(9):1739-1757. PubMed ID: 36187400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
    Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
    Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary malignant melanoma of the esophagus: a case report.
    Li YH; Li X; Zou XP
    World J Gastroenterol; 2014 Mar; 20(10):2731-4. PubMed ID: 24627611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.